Efficacy of nebulized L-epinephrine for treatment of croup: a randomized, double-blind study

Area of Science:

• Pediatric Emergency Medicine
• Respiratory Illnesses
• Clinical Pharmacology

Background:

• Croup is a common respiratory infection in children, often causing upper airway obstruction.
• Dexamethasone is a standard treatment, but its effectiveness can be enhanced.

Purpose of the Study:

• To compare the efficacy of L-epinephrine plus dexamethasone versus dexamethasone alone in treating pediatric croup.
• To evaluate the impact on clinical croup severity scores and vital signs.

Main Methods:

• A randomized, double-blind clinical trial involving 174 children aged 6 months to 6 years with croup.
• Patients received dexamethasone, followed by either nebulized L-epinephrine or saline placebo.
• Westley croup scores and vital signs were monitored for 120 minutes.

Main Results:

• A statistically significant difference was observed in mean croup scores between the two groups (P < 0.009).
• Significant differences were also noted in mean heart rate (P < 0.026).
• Nebulized L-epinephrine demonstrated a considerable difference in the reduction of croup score velocity compared to placebo.

Conclusions:

• The combination of L-epinephrine and dexamethasone is more effective than dexamethasone alone for treating croup in children.
• Nebulized L-epinephrine can accelerate symptom improvement in pediatric croup management.